Q3 2024 OvaSuiteSM revenue of $2.3 million and volume of 6,001 units Cash utilization for the third quarter was $2.9 million, a decrease of 12% compared to the second quarter of 2024 Full year 2024 ...
Good morning, ladies and gentlemen and welcome to Aspira Women's Health Incorporated Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following ...
She is a gynecologic oncologist specializing in treating gynecologic malignancies with both surgical and systemic therapies. Dr. Fleming will divide her time evenly between overseeing daily operations ...